Clinical trial NCT06653465: Intravenous Acetaminophen for Postoperative Delirium in Older Patients Recovering From Major Noncardiac Surgery
Official title: Intravenous Acetaminophen for Postoperative Delirium in Older Patients Recovering From Major Noncardiac Surgery: a Randomised Controlled Study
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: PHASE2
PHASE3
Conditions: Delirium in Old Age
Keywords: postoperative delirium
acetaminophen
elderly patient
Lead sponsor: RenJi Hospital
Sponsor class: OTHER
First posted: 2024-10-22
Enrollment: 1930
Sex: ALL
Minimum age (years): 65
Standard ages: OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: PREVENTION

Brief summary: Investigators propose this multi-center randomised controlled study to test the preventive effect of intravenouse acetaminophen in delirium over 5 postoperative days among older patients recovering from major non-cardiac surgery.

Detailed description: Delirium is a common complication in elderly patients after major surgeries and can lead to poor outcomes such as neurocognitive decline. Acetaminophen is a widely used adjuvant for perioperative multimodal analgesia. It can effectively alleviate postoperative pain, promote opioid-sparing and exert anti-neuroinflammatory response, showing strong potential for preventing postoperative delirium. There is evidence that intravenous acetaminophen reduces delirium in older patients following cardiac surgery, but its effectiveness is inconclusive among non-cardiac surgical patients. Investigators propose this multi-center, randomized, placebo-controlled, parallel-group trial in patients aged \>65 years old scheduled for non-cardiac major surgery with general anesthesia expected to last at least 2 h. A total of 1930 elderly patients will be enrolled and randomized at 1:1 ratio to acetaminophen or saline placebo groups, stratified by age, education level, and trial site with random-sized blocking. Acetaminophen or saline will be given when the surgical suture begin at the end of surgery and thereafter a total of 7 doses within 48h after surgery. The primary outcome will be the incidence of delirium, assessed twice daily, through the five postoperative days. Secondary outcomes will include pain scores with movement, opioid use within the first 48 postoperative hours, severity of delirium, ICU and hospital lengths of stay.

Eligibility criteria: Inclusion Criteria:

1. Age ≥ 65 years.
2. Scheduled for non-cardiac major surgery with general anesthesia that is expected to last more than 2h.
3. ASA Physical Status I-III.
4. Weight \>50 kg.
5. Written informed consent.

Exclusion Criteria:

1. Pre-existing neuropsychiatric diseases (Alzheimer's disease, Schizophrenia, Parkinson's Disease, Seizures, etc.).
2. Pre-existing cognitive impairment (MMSE\<18).
3. Preoperative delirium.
4. Severe circulatory instability (preoperative left ventricular ejection fraction less than 30%, unstable angina, severe coronary artery disease, sick sinus syndrome, etc.).
5. Contraindication to the acetaminophen use, including serum creatinine \> 177µmol/L or aminotransferses \> 3 times the upper limit of normal.
6. Alcohol or drug abuse within a year before surgery.
7. Inability to communicate because of severe visual/auditory dysfunction or language barrier.

Primary outcomes:
measure: Incidence of postoperative delirium
timeFrame: Participants will be followed up during the first 5 postoperative days.
Secondary outcomes:
measure: Delirium type
timeFrame: Participants will be followed up during the first 5 postoperative days.
measure: Delirium severity
timeFrame: Participants will be followed up during the first 5 postoperative days.
measure: Pain scores
timeFrame: Participants will be followed up during the first 5 postoperative days.
measure: Total opioid consumption
timeFrame: Participants will be followed up during the first 5 postoperative days.
measure: Delirium duration
timeFrame: Participants will be followed up during the first 5 postoperative days.
Other outcomes:
measure: Cognitive function
timeFrame: Cognitive function will be evaluated on the fifth day after operation.
measure: Length of days in ICU and hospital after surgery
timeFrame: one month
measure: All cause mortality
timeFrame: one month
Locations:
Study officials:
affiliation: Anesthesiology, Renji Hospital, Shanghai Jiao Tong University, School of Medicine Shanghai, China
name: LIQUN YANG, MD
role: PRINCIPAL_INVESTIGATOR
References: